Ankündigung • Jul 25
Grauer & Weil (India) Limited to Report Q1, 2027 Results on Aug 04, 2026 Grauer & Weil (India) Limited announced that they will report Q1, 2027 results on Aug 04, 2026 Ankündigung • May 28
Grauer & Weil (India) Limited announces Annual dividend, payable on October 16, 2026 Grauer & Weil (India) Limited announced Annual dividend of INR 0.5000 per share payable on October 16, 2026, ex-date on September 09, 2026 and record date on September 09, 2026. Reported Earnings • May 27
Full year 2026 earnings released: EPS: ₹3.62 (vs ₹3.47 in FY 2025) Full year 2026 results: EPS: ₹3.62 (up from ₹3.47 in FY 2025). Revenue: ₹12.4b (up 9.3% from FY 2025). Net income: ₹1.64b (up 4.3% from FY 2025). Profit margin: 13% (in line with FY 2025). Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 11% per year. Ankündigung • May 26
Grauer & Weil (India) Limited, Annual General Meeting, Sep 16, 2026 Grauer & Weil (India) Limited, Annual General Meeting, Sep 16, 2026. Valuation Update With 7 Day Price Move • Apr 06
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹63.60, the stock trades at a trailing P/E ratio of 20.6x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 25% over the past three years. Valuation Update With 7 Day Price Move • Mar 23
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹51.57, the stock trades at a trailing P/E ratio of 16.7x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 14% over the past three years. Buy Or Sell Opportunity • Feb 17
Now 21% overvalued Over the last 90 days, the stock has fallen 14% to ₹71.16. The fair value is estimated to be ₹58.95, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.2% over the last 3 years. Earnings per share has grown by 9.8%. Reported Earnings • Feb 16
Third quarter 2026 earnings released: EPS: ₹0.71 (vs ₹0.95 in 3Q 2025) Third quarter 2026 results: EPS: ₹0.71 (down from ₹0.95 in 3Q 2025). Revenue: ₹3.03b (up 10% from 3Q 2025). Net income: ₹323.3m (down 25% from 3Q 2025). Profit margin: 11% (down from 16% in 3Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 15% per year. Reported Earnings • Nov 07
Second quarter 2026 earnings released: EPS: ₹0.85 (vs ₹0.83 in 2Q 2025) Second quarter 2026 results: EPS: ₹0.85 (up from ₹0.83 in 2Q 2025). Revenue: ₹3.03b (up 19% from 2Q 2025). Net income: ₹385.7m (up 2.6% from 2Q 2025). Profit margin: 13% (down from 15% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 14% per year whereas the company’s share price has increased by 18% per year. Upcoming Dividend • Jul 30
Upcoming dividend of ₹0.50 per share Eligible shareholders must have bought the stock before 06 August 2025. Payment date: 12 September 2025. Payout ratio is a comfortable 14% and this is well supported by cash flows. Trailing yield: 0.5%. Lower than top quartile of Indian dividend payers (1.2%). Lower than average of industry peers (0.7%). Reported Earnings • Jul 25
Full year 2025 earnings released: EPS: ₹3.47 (vs ₹3.23 in FY 2024) Full year 2025 results: EPS: ₹3.47 (up from ₹3.23 in FY 2024). Revenue: ₹11.3b (up 6.1% from FY 2024). Net income: ₹1.57b (up 7.5% from FY 2024). Profit margin: 14% (in line with FY 2024). Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has increased by 48% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jun 25
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to ₹108, the stock trades at a trailing P/E ratio of 31.2x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 280% over the past three years. Reported Earnings • May 28
Full year 2025 earnings released: EPS: ₹3.47 (vs ₹3.23 in FY 2024) Full year 2025 results: EPS: ₹3.47 (up from ₹3.23 in FY 2024). Revenue: ₹11.8b (up 10% from FY 2024). Net income: ₹1.57b (up 7.5% from FY 2024). Profit margin: 13% (in line with FY 2024). Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Feb 07
Third quarter 2025 earnings released: EPS: ₹0.95 (vs ₹0.94 in 3Q 2024) Third quarter 2025 results: EPS: ₹0.95 (up from ₹0.94 in 3Q 2024). Revenue: ₹2.87b (flat on 3Q 2024). Net income: ₹431.2m (flat on 3Q 2024). Profit margin: 15% (in line with 3Q 2024). Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has increased by 48% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Oct 25
Second quarter 2025 earnings released: EPS: ₹0.83 (vs ₹0.82 in 2Q 2024) Second quarter 2025 results: EPS: ₹0.83 (up from ₹0.82 in 2Q 2024). Revenue: ₹2.68b (up 7.2% from 2Q 2024). Net income: ₹376.1m (flat on 2Q 2024). Profit margin: 14% (in line with 2Q 2024). Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has increased by 51% per year, which means it is tracking significantly ahead of earnings growth. Ankündigung • Oct 17
Grauer & Weil (India) Limited to Report Q2, 2025 Results on Oct 24, 2024 Grauer & Weil (India) Limited announced that they will report Q2, 2025 results on Oct 24, 2024 Upcoming Dividend • Sep 13
Upcoming dividend of ₹0.50 per share Eligible shareholders must have bought the stock before 20 September 2024. Payment date: 25 October 2024. Payout ratio is a comfortable 15% and this is well supported by cash flows. Trailing yield: 0.5%. Lower than top quartile of Indian dividend payers (1.0%). In line with average of industry peers (0.6%). Valuation Update With 7 Day Price Move • Aug 19
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹101, the stock trades at a trailing P/E ratio of 28.7x. Average forward P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 266% over the past three years. Ankündigung • Aug 13
Grauer & Weil (India) Limited, Annual General Meeting, Sep 25, 2024 Grauer & Weil (India) Limited, Annual General Meeting, Sep 25, 2024. Reported Earnings • Aug 13
First quarter 2025 earnings released: EPS: ₹1.12 (vs ₹0.81 in 1Q 2024) First quarter 2025 results: EPS: ₹1.12 (up from ₹0.81 in 1Q 2024). Revenue: ₹2.73b (up 36% from 1Q 2024). Net income: ₹507.1m (up 37% from 1Q 2024). Profit margin: 19% (in line with 1Q 2024). Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has increased by 45% per year, which means it is tracking significantly ahead of earnings growth. Ankündigung • Aug 05
Grauer & Weil (India) Limited to Report Q1, 2025 Results on Aug 12, 2024 Grauer & Weil (India) Limited announced that they will report Q1, 2025 results on Aug 12, 2024 Board Change • Aug 01
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 2 experienced directors. 5 highly experienced directors. Non-Executive Independent Director Ayush Agarwala was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Buy Or Sell Opportunity • Jul 26
Now 22% overvalued Over the last 90 days, the stock has fallen 5.7% to ₹87.76. The fair value is estimated to be ₹72.01, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Earnings per share has grown by 22%. Buy Or Sell Opportunity • Jul 09
Now 20% overvalued Over the last 90 days, the stock has fallen 11% to ₹86.87. The fair value is estimated to be ₹72.18, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Earnings per share has grown by 22%. Valuation Update With 7 Day Price Move • Jun 14
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹92.88, the stock trades at a trailing P/E ratio of 28.8x. Average forward P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 243% over the past three years. Buy Or Sell Opportunity • Jun 12
Now 25% overvalued after recent price rise Over the last 90 days, the stock has risen 5.3% to ₹88.61. The fair value is estimated to be ₹71.02, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 18% over the last 3 years. Earnings per share has grown by 22%. Ankündigung • May 30
Grauer & Weil (India) Limited Recommends Dividend for the Financial Year 2023-24 Grauer & Weil (India) Limited at its board meeting held on May 28, 2024, the Board of Directors, subject to approvals of the Shareholders at the upcoming Annual General Meeting, has recommended the payments of Dividend @ 50%, that is INR 0.50 per equity share of INR 1 each for the Financial Year 2023-24, to all those Shareholders whose names appears on the Record Date, for Dividend purposes. Reported Earnings • May 29
Full year 2024 earnings released: EPS: ₹3.23 (vs ₹2.49 in FY 2023) Full year 2024 results: EPS: ₹3.23 (up from ₹2.49 in FY 2023). Revenue: ₹11.0b (up 12% from FY 2023). Net income: ₹1.46b (up 30% from FY 2023). Profit margin: 13% (up from 12% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 49% per year, which means it is tracking significantly ahead of earnings growth. Ankündigung • May 23
Grauer & Weil (India) Limited to Report Q4, 2024 Results on May 28, 2024 Grauer & Weil (India) Limited announced that they will report Q4, 2024 results on May 28, 2024 New Risk • Feb 22
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.0% average weekly change). Reported Earnings • Feb 10
Third quarter 2024 earnings released: EPS: ₹1.89 (vs ₹1.52 in 3Q 2023) Third quarter 2024 results: EPS: ₹1.89 (up from ₹1.52 in 3Q 2023). Revenue: ₹2.94b (up 17% from 3Q 2023). Net income: ₹427.5m (up 24% from 3Q 2023). Profit margin: 14% (in line with 3Q 2023). Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has increased by 60% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Feb 07
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹183, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 344% over the past three years. Valuation Update With 7 Day Price Move • Jan 12
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹151, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 30x in the Chemicals industry in India. Total returns to shareholders of 252% over the past three years. Buying Opportunity • Dec 29
Now 20% undervalued The stock has been flat over the last 90 days. The fair value is estimated to be ₹164, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 22% over the last 3 years. Earnings per share has grown by 24%. Revenue is forecast to grow by 23% in a year. Earnings is forecast to grow by 40% in the next year. Reported Earnings • Nov 14
Second quarter 2024 earnings released: EPS: ₹1.65 (vs ₹1.23 in 2Q 2023) Second quarter 2024 results: EPS: ₹1.65 (up from ₹1.23 in 2Q 2023). Revenue: ₹2.50b (up 22% from 2Q 2023). Net income: ₹374.6m (up 34% from 2Q 2023). Profit margin: 15% (up from 14% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has increased by 48% per year, which means it is tracking significantly ahead of earnings growth. Ankündigung • Nov 04
Grauer & Weil (India) Limited to Report Q2, 2024 Results on Nov 09, 2023 Grauer & Weil (India) Limited announced that they will report Q2, 2024 results at 3:30 PM, Indian Standard Time on Nov 09, 2023 Valuation Update With 7 Day Price Move • Aug 18
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹133, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 220% over the past three years. Ankündigung • Aug 01
Grauer & Weil (India) Limited to Report Q1, 2024 Results on Aug 10, 2023 Grauer & Weil (India) Limited announced that they will report Q1, 2024 results at 3:30 PM, Indian Standard Time on Aug 10, 2023 Upcoming Dividend • Jul 28
Upcoming dividend of ₹0.80 per share at 0.7% yield Eligible shareholders must have bought the stock before 04 August 2023. Payment date: 09 September 2023. Payout ratio is a comfortable 16% and this is well supported by cash flows. Trailing yield: 0.7%. Lower than top quartile of Indian dividend payers (1.5%). Lower than average of industry peers (0.9%). Reported Earnings • Jul 21
Full year 2023 earnings released: EPS: ₹4.98 (vs ₹3.48 in FY 2022) Full year 2023 results: EPS: ₹4.98 (up from ₹3.48 in FY 2022). Revenue: ₹9.83b (up 28% from FY 2022). Net income: ₹1.13b (up 43% from FY 2022). Profit margin: 12% (up from 10% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 10.0% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 42% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • May 30
Full year 2023 earnings released: EPS: ₹4.98 (vs ₹3.48 in FY 2022) Full year 2023 results: EPS: ₹4.98 (up from ₹3.48 in FY 2022). Revenue: ₹10.0b (up 30% from FY 2022). Net income: ₹1.13b (up 43% from FY 2022). Profit margin: 11% (up from 10% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has increased by 44% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Feb 12
Third quarter 2023 earnings released: EPS: ₹1.52 (vs ₹1.03 in 3Q 2022) Third quarter 2023 results: EPS: ₹1.52 (up from ₹1.03 in 3Q 2022). Revenue: ₹2.51b (up 24% from 3Q 2022). Net income: ₹344.4m (up 48% from 3Q 2022). Profit margin: 14% (up from 12% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 20% per year. Recent Insider Transactions • Dec 20
Non-Executive Independent Director recently sold ₹5.9m worth of stock On the 16th of December, Suresh Pareek sold around 64k shares on-market at roughly ₹92.22 per share. This transaction amounted to 4.4% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth ₹14m. Insiders have been net sellers, collectively disposing of ₹37m more than they bought in the last 12 months. Ankündigung • Dec 08
Grauer & Weil (India) Limited (BSE:505710) agreed to acquire Kamtress Automation Systems Private Limited from Poona Bottling Company Private Limited for INR 51 million. Grauer & Weil (India) Limited (BSE:505710) agreed to acquire Kamtress Automation Systems Private Limited from Poona Bottling Company Private Limited for INR 51 million on December 6, 2022. The consideration is paid in cash. Grauer & Weil (India) acquiring 1,50,000 Equity shares of amtress Automation Systems for price of INR 340. Kamtress Automation has a turnover of INR 202.12 million of FY 2021-22. Post completion KAS become wholly owned subsidiary to Grauer & Weil. Board of Directors of Grauer & Weil approved the acquisition. The transaction is expected to close on January 5, 2023. Recent Insider Transactions • Dec 01
Non-Executive Independent Director recently sold ₹14m worth of stock On the 29th of November, Suresh Pareek sold around 137k shares on-market at roughly ₹100 per share. This transaction amounted to 8.7% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹31m more than they bought in the last 12 months. Valuation Update With 7 Day Price Move • Nov 30
Investor sentiment improved over the past week After last week's 15% share price gain to ₹107, the stock trades at a trailing P/E ratio of 24.8x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 129% over the past three years. Recent Insider Transactions • Nov 18
Insider recently sold ₹6.4m worth of stock On the 15th of November, Veena Pareek sold around 65k shares on-market at roughly ₹98.35 per share. This transaction amounted to 52% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹15m more than they bought in the last 12 months. Valuation Update With 7 Day Price Move • Oct 07
Investor sentiment improved over the past week After last week's 15% share price gain to ₹77.05, the stock trades at a trailing P/E ratio of 22.2x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 89% over the past three years. Recent Insider Transactions • Oct 01
Insider recently sold ₹4.2m worth of stock On the 29th of September, Veena Pareek sold around 63k shares on-market at roughly ₹67.68 per share. This transaction amounted to 23% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹8.3m more than they bought in the last 12 months. Ankündigung • Sep 24
Grauer & Weil (India) Limited Declares Dividend for the Financial Year Ended March 31, 2022 Grauer & Weil (India) Limited declared dividend of INR 0.65 per equity shares of INR 1 each for the financial year ended March 31, 2022 at the AGM held on September 22, 2022. Recent Insider Transactions • Sep 16
Insider recently sold ₹218k worth of stock On the 13th of September, Vinod Haritwal sold around 3k shares on-market at roughly ₹72.50 per share. This transaction amounted to 49% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of ₹568k more than they bought in the last 12 months. Upcoming Dividend • Sep 07
Upcoming dividend of ₹0.65 per share Eligible shareholders must have bought the stock before 14 September 2022. Payment date: 22 October 2022. Payout ratio is a comfortable 19% and this is well supported by cash flows. Trailing yield: 1.0%. Lower than top quartile of Indian dividend payers (1.6%). Higher than average of industry peers (0.7%). Upcoming Dividend • Sep 07
Upcoming dividend of ₹0.65 per share Eligible shareholders must have bought the stock before 14 September 2022. Payment date: 22 October 2022. Payout ratio is a comfortable 19% and this is well supported by cash flows. Trailing yield: 1.0%. Lower than top quartile of Indian dividend payers (1.6%). Higher than average of industry peers (0.7%). Reported Earnings • Sep 01
Full year 2022 earnings released: EPS: ₹3.47 (vs ₹3.04 in FY 2021) Full year 2022 results: EPS: ₹3.47 (up from ₹3.04 in FY 2021). Revenue: ₹7.68b (up 27% from FY 2021). Net income: ₹787.6m (up 14% from FY 2021). Profit margin: 10% (down from 11% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 11% per year. Board Change • Aug 25
Less than half of directors are independent Following the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Additional Non-Executive Independent Director Ayush Agarwala was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Ankündigung • Aug 12
Grauer & Weil (India) Limited, Annual General Meeting, Sep 22, 2022 Grauer & Weil (India) Limited, Annual General Meeting, Sep 22, 2022. Ankündigung • Aug 05
Grauer & Weil (India) Limited Appoints Ayush Agarwala as an Additional Director Grauer & Weil (India) Limited approved the appointment of Mr. Ayush Agarwala as an Additional Director (Non-Executive Independent Director) of the Company with effect from August 04, 2022, to hold office upto the date of next Annual General Meeting of the Company. Mr. Ayush Agarwala heads the dispute practice in the Mumbai office of K Law (Legal firm). Prior to K law, he was associated with firms like Khaitan & Co. and AZB & Partners. He is an advocate with a career spanning of over 13 years and have vast experience in international and domestic disputes, white collar crimes and insolvency and bankruptcy. He has advised several corporate power houses and multinational companies, both domestic and international spanning various industries and sectors. He has extensive experience in sectors including shareholder disputes, infrastructure, insurance, financial institutions, telecom, manufacturing, information technology and consumer. Ankündigung • Aug 03
Grauer & Weil (India) Limited to Report Q1, 2023 Results on Aug 09, 2022 Grauer & Weil (India) Limited announced that they will report Q1, 2023 results at 3:30 PM, Indian Standard Time on Aug 09, 2022 Recent Insider Transactions • Jun 07
Insider recently sold ₹350k worth of stock On the 2nd of June, Vinod Haritwal sold around 5k shares on-market at roughly ₹70.00 per share. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Reported Earnings • Jun 02
Full year 2022 earnings released: EPS: ₹3.47 (vs ₹3.04 in FY 2021) Full year 2022 results: EPS: ₹3.47 (up from ₹3.04 in FY 2021). Revenue: ₹7.82b (up 29% from FY 2021). Net income: ₹787.6m (up 14% from FY 2021). Profit margin: 10% (down from 11% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 9% per year. Ankündigung • May 31
Grauer & Weil (India) Limited Recommends Dividend for the Financial Year 2021-22 Grauer & Weil (India) Limited at its board meeting held on May 30, 2022 recommended dividend of INR 0.65 per share for the financial year 2021-22, subject to approval at annual general meeting. Ankündigung • May 24
Grauer & Weil (India) Limited to Report Q4, 2022 Results on May 30, 2022 Grauer & Weil (India) Limited announced that they will report Q4, 2022 results on May 30, 2022 Valuation Update With 7 Day Price Move • May 20
Investor sentiment improved over the past week After last week's 23% share price gain to ₹80.30, the stock trades at a trailing P/E ratio of 20.1x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 62% over the past three years. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Non-Executive Independent Director Prerna Goradia was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Mar 07
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Non-Executive Independent Director Prerna Goradia was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Ankündigung • Mar 06
Grauer & Weil (India) Limited Announces Resignation of as Shashikant Sakhalkar as Non-Executive Independent Director Grauer & Weil (India) Limited announced that Mr. Shashikant Sakhalkar, Non-executive Independent Director of the Company has resigned from the Directorship of the Company with effect from March 03, 2022. Valuation Update With 7 Day Price Move • Jan 04
Investor sentiment improved over the past week After last week's 17% share price gain to ₹66.50, the stock trades at a trailing P/E ratio of 16.5x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 37% over the past three years. Executive Departure • Oct 07
Chief Executive Officer Vinod Haritwal has left the company On the 30th of September, Vinod Haritwal's tenure as Chief Executive Officer ended. As of June 2021, Vinod still personally held only 31.00k shares (₹1.7m worth at the time). A total of 2 executives have left over the last 12 months. The current median tenure of the management team is 2.92 years. Upcoming Dividend • Sep 13
Upcoming dividend of ₹0.50 per share Eligible shareholders must have bought the stock before 20 September 2021. Payment date: 29 October 2021. Trailing yield: 0.8%. Lower than top quartile of Indian dividend payers (1.5%). In line with average of industry peers (0.7%). Reported Earnings • Aug 18
First quarter 2022 earnings released: EPS ₹0.86 (vs ₹0.05 in 1Q 2021) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹1.35b (up 113% from 1Q 2021). Net income: ₹195.0m (up ₹183.9m from 1Q 2021). Profit margin: 14% (up from 1.8% in 1Q 2021). The increase in margin was driven by higher revenue. Executive Departure • Jul 13
CEO & Whole Time Director Vinod Haritwal has left the company On the 30th of June, Vinod Haritwal was replaced as CEO by Yogesh Samat after 9.8 years in the role. As of March 2021, Vinod still personally held only 31.00k shares (₹1.2m worth at the time). A total of 2 executives have left over the last 12 months. The current median tenure of the management team is 2.67 years. Under Vinod's leadership, the company delivered a total shareholder return of 857%. Reported Earnings • Jul 04
Full year 2021 earnings released: EPS ₹3.04 (vs ₹3.35 in FY 2020) The company reported a poor full year result with weaker earnings and profit margins, although revenues were flat. Full year 2021 results: Revenue: ₹6.21b (flat on FY 2020). Net income: ₹688.2m (down 9.3% from FY 2020). Profit margin: 11% (down from 12% in FY 2020). Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 11% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Jul 03
Investor sentiment improved over the past week After last week's 19% share price gain to ₹65.70, the stock trades at a trailing P/E ratio of 24.4x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 41% over the past three years. Valuation Update With 7 Day Price Move • Jun 08
Investor sentiment improved over the past week After last week's 16% share price gain to ₹59.10, the stock trades at a trailing P/E ratio of 21.9x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 16% over the past three years. Valuation Update With 7 Day Price Move • May 07
Investor sentiment improved over the past week After last week's 19% share price gain to ₹52.85, the stock trades at a trailing P/E ratio of 19.6x. Average trailing P/E is 19x in the Chemicals industry in India. Total loss to shareholders of 8.2% over the past three years. Executive Departure • Feb 16
Non-Executive Independent Director has left the company On the 11th of February, Aarti Shah's tenure as Non-Executive Independent Director ended after 6.3 years in the role. As of December 2020, Aarti personally held only 2.30k shares (₹98k worth at the time). A total of 2 executives have left over the last 12 months. Reported Earnings • Feb 14
Third quarter 2021 earnings released: EPS ₹1.07 (vs ₹0.79 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹1.71b (up 5.5% from 3Q 2020). Net income: ₹243.1m (up 35% from 3Q 2020). Profit margin: 14% (up from 11% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has fallen by 13% per year, which means it is performing significantly worse than earnings. Ankündigung • Feb 13
Grauer & Weil (India) Limited Announces Resignation of Aarti Shah as Non-Executive Independent Director Grauer & Weil (India) Limited announced that Mrs. Aarti Shah Non-executive Independent Director of the company has resigned from the Directorship of the company, effective February 11, 2021. Is New 90 Day High Low • Jan 07
New 90-day high: ₹45.40 The company is up 29% from its price of ₹35.15 on 09 October 2020. The Indian market is up 20% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 23% over the same period. Is New 90 Day High Low • Dec 16
New 90-day high: ₹43.75 The company is up 11% from its price of ₹39.45 on 17 September 2020. The Indian market is up 15% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. Is New 90 Day High Low • Oct 09
New 90-day low: ₹35.15 The company is down 7.0% from its price of ₹37.85 on 10 July 2020. The Indian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period. Is New 90 Day High Low • Sep 22
New 90-day low: ₹35.80 The company is down 5.0% from its price of ₹37.65 on 24 June 2020. The Indian market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period. Ankündigung • Aug 29
Grauer & Weil (India) Limited to Report Q1, 2021 Results on Sep 07, 2020 Grauer & Weil (India) Limited announced that they will report Q1, 2021 results on Sep 07, 2020 
